LRRA Larrea Biosciences Corp. featured news, full reports, and detailed charts
Larrea Biosciences Corp. (LRRA/LRRA.PK) Wrap Up:
Larrea Biosciences Corporation, through its subsidiary, LarreaRx, Inc., engages in manufacturing, licensing, and distributing green dietary supplements. Its products are derived from the desert shrub, Larrea tridentate. The proprietary extract from this plant include Larreastatin, which is the key ingredient in company’s products comprising dietary supplement capsules, topical lotion, and topical spray. The company sells its products through retail channels, direct marketing channels, and distributors under LarreaRx and Shegoi trade names. It has operations in the United States and Canada. Larrea Biosciences is headquartered in Houston, Texas.Larrea Biosciences Corp. (LRRA:OTC)
|
Market Cap
30.6K
|
Total Revenue
302.9K
|
|
|
EBITDA
44.5K
|
DILUTED EPS TTM
0.00
|
|
|
P/E
--
|
P/S
0.1x
|
|
|
Return On Asset
-27.86
|
Return On Equity
12.82
|
|
| K = Thousands M = Millions B = Billions | ||
LRRA Top Compensated Officers
Executives, Board Directors
Key developments for Larrea Biosciences Corp. (LRRA)
Larrea Biosciences Corp. announced the appointment of Mr. Gary D. Woerz as President and CFO and Director. Mr. Woerz has previously served as Chief Financial Officer of Larrea Biosciences. He has more than thirty years experience in private and public companies. He most recently was CFO for Virexx Medical. He has an MBA from Pepperdine University. Larrea also announced the appointment of three new independent outside directors Dr. Dennis Clark, Dr. Shengmei Qi, M.D., and Dr. Richard Ascione all of whom are preeminently qualified to help the Company review, research, and retain new products, as well as assist in formulations with the existing product line to create 'patented health care solutions' for individuals and animals.
On 07/31/2008, Larrea Biosciences Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
On 03/17/2008, Larrea Biosciences Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
LRRA Competitors
| Company | Last | Change | |
| No competitor information is available for LRRA. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | LRRA | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.1x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
LRRA |
||
LRRA transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||